A cohort study of the performance of ASpirin-FREE therapy after successful percutaneous coronary intervention for acute coronary syndrome
Not Applicable
Recruiting
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0008182
- Lead Sponsor
- Wonkwang University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1. Patients who successfully received a drug-eluting stent after diagnosis of acute coronary syndrome
2. Patients who voluntarily participated in this study and gave written consent
Exclusion Criteria
1. Age less than 19 years
2. Contraindications to prasugrel or ticagrelor: history of intracranial hemorrhage, active bleeding, etc.
3. Subjects whose life expectancy is less than 1 year
4. Subjects who are judged unsuitable by investigators
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of stent thrombosis
- Secondary Outcome Measures
Name Time Method Target vessek failure